Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2025)

Perspective Therapeutics (CATX) has disclosed Change in Interest Receivables for 2 consecutive years, with -$163000.0 as the latest value for Q4 2025.

  • Quarterly Change in Interest Receivables fell 118.52% to -$163000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $142000.0 through Dec 2025, down 83.86% year-over-year, with the annual reading at $142000.0 for FY2025, 83.86% down from the prior year.
  • Change in Interest Receivables hit -$163000.0 in Q4 2025 for Perspective Therapeutics, down from $19000.0 in the prior quarter.
  • In the past five years, Change in Interest Receivables ranged from a high of $880000.0 in Q4 2024 to a low of -$163000.0 in Q4 2025.